Strategy paper on iPSC as source

Summary
Strategy paper on iPSC as source for Advanced Therapies - banking haplotyped iPSC and universal allogenic resource - definition of centers of excellence for clinical grade iPSC production - off-the shelf iPSC-derived products and immunogenicity tests - automation and scalable manufacturing platform iPSC-derived products - data base of clinical grade iPSC lines